Rockefeller Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.9M Sell
127,106
-38,450
-23% -$3.66M 0.02% 559
2025
Q4
$13.4M Sell
165,556
-100,923
-38% -$8.69M 0.02% 557
2025
Q3
$23.3M Sell
266,479
-22,995
-8% -$2.05M 0.05% 368
2025
Q2
$24M Buy
289,474
+111,375
+63% +$9.31M 0.05% 332
2025
Q1
$14.9M Buy
178,099
+93,582
+111% +$8.71M 0.04% 443
2024
Q4
$7.79M Buy
+84,517
New +$8.13M 0.02% 609
2023
Q1
Sell
-7
Closed 3063
2022
Q4
$0 Sell
7
-203
-97% -$9.51K ﹤0.01% 4058
2022
Q3
$10K Buy
210
+40
+24% +$2K ﹤0.01% 3086
2022
Q2
$7K Sell
170
-20
-11% -$895 ﹤0.01% 3303
2022
Q1
$8K Buy
+190
New +$8.5K ﹤0.01% 3162

Other funds holding LMAT

Rockefeller Capital Management's LMAT Position: Q1 2026 in Review

Rockefeller Capital Management reduced its LeMaitre Vascular (LMAT) stake by 23% in Q1 2026, selling an estimated $3.66M and leaving 127,106 shares worth $13.9M. The position accounts for 0.02% of the portfolio, ranked #559.

Rockefeller Capital Management first reported a position in LMAT in Q1 2022 and has held it in 10 quarters since. The position peaked at $24M in Q2 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Rockefeller Capital Management held 127,106 shares of LeMaitre Vascular worth $13.9M as of Q1 2026.
  • Rockefeller Capital Management sold 38,450 LeMaitre Vascular shares in Q1 2026, an estimated $3.66M.
  • LeMaitre Vascular made up 0.02% of Rockefeller Capital Management's portfolio in Q1 2026, its #559 holding.
  • Rockefeller Capital Management first reported a position in LeMaitre Vascular in Q1 2022 and has held it in 10 quarters since.
  • Rockefeller Capital Management's LeMaitre Vascular position peaked at $24M in Q2 2025.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.